Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development
Accounts of Chemical Research · 07.02.2023 · 56 (3) · 224-236
DOI: 10.1021/acs.accounts.2c00464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Accounts of Chemical Research, online erschienen am 09.01.2023. Verfasst von Mei Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine …. Hauptthemen laut MEDLINE: COVID-19, Nanostructures. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Beijing Municipality, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmac…
- Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, No. 11, First N…
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, No. 27, Taiping Road, Beijing 100850, China.
ORCID-Profile: Mei Lu, Haonan Xing, Yuanyu Huang, Xing-Jie Liang
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Beijing Municipality
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Beijing Nova Program
- Beijing-Tianjin-Hebei Basic Research Cooperation Project
Zitieren
APA
Lu, M., Xing, H., Zheng, A., Huang, Y., & Liang, X. J. (2023). Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development. Accounts of Chemical Research, 56(3), 224-236. https://doi.org/10.1021/acs.accounts.2c00464
Vancouver
Lu M, Xing H, Zheng A, Huang Y, Liang XJ. Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development. Accounts of Chemical Research. 2023;56(3):224-236. doi:10.1021/acs.accounts.2c00464
BibTeX
@article{Lu2023,
author = {Lu, Mei and Xing, Haonan and Zheng, Aiping and Huang, Yuanyu and Liang, Xing-Jie},
title = {Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development},
journal = {Accounts of Chemical Research},
year = {2023},
volume = {56},
number = {3},
pages = {224--236},
doi = {10.1021/acs.accounts.2c00464}
}
EUVIMED